Table 2.
VA improvement, log-unit | Group* | |||
---|---|---|---|---|
Fluoxetine | Placebo | |||
n | % | n | % | |
0 | 0 | 0 | 3 | 20.0 |
0.1 | 2 | 10.0 | 7 | 46.6 |
0.2 | 8 | 40.0 | 4 | 26.7 |
0.3 | 10 | 50.0 | 1 | 6.7 |
Total | 20 | 100 | 15 | 100 |
*P-value = 0.003; χ2-test
VA visual acuity
VA improvement, log-unit | Group* | |||
---|---|---|---|---|
Fluoxetine | Placebo | |||
n | % | n | % | |
0 | 0 | 0 | 3 | 20.0 |
0.1 | 2 | 10.0 | 7 | 46.6 |
0.2 | 8 | 40.0 | 4 | 26.7 |
0.3 | 10 | 50.0 | 1 | 6.7 |
Total | 20 | 100 | 15 | 100 |
*P-value = 0.003; χ2-test
VA visual acuity